Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLs

Molecular Cancer Therapeutics (2012) - Comments
pubmed: 22532603 doi: 10.1158/1535-7163.mct-11-0814 issn: 1538-8514 issn: 1535-7163

Ali R. Jazirehi, James S. Economou